FindTrial
Sign In

A study to see whether intravenous iron treatment can improve hemoglobin, quality of life, daily functioning, and reduce the need for blood transfusions in women with breast and ovarian cancer receiving chemotherapy.

Impact of intravenous iron therapy on hemoglobin levels, quality of life, functional status and frequency of red cell transfusions in patients with carcinoma breast and ovary receiving neoadjuvant chemotherapy - a single arm prospective study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093272
Enrollment
220
Registered
2025-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Akshay Batra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ? Patients willing to participate in the study. ? Patients with Carcinoma Breast and, or, Carcinoma Ovary planned for Neoadjuvant Chemotherapy, and are considered for IV Iron Therapy. ? Age group between 18 to 70 years ? Pre-Treatment Hb less than 12.0 g per dL

Exclusion criteria

Exclusion criteria: ? Known allergy to Iron therapy. ? IV Iron Therapy in the last 3 months. ? Blood Transfusion in the last 3 months.

Design outcomes

Primary

MeasureTime frame
Hemoglobin levels at the end of intravenous iron therapy and neoadjuvant chemotherapy.Timepoint: Baseline Hb level - Before the start of first cycle of neoadjuvant chemotherapy. Hb level at 6 weeks - after the start of first cycle of neoadjuvant chemotherapy.—

Secondary

MeasureTime frame
Red cell transfusion rateTimepoint: Red cell transfusions received by the patients during the study enrollment period will be documented.;Quality of Life (QoL) [FACT-An (Functional Assessment of Cancer Therapy-Anemia)]Timepoint: Before, and After IV Iron Therapy;Functional Status (ECOG performance status (Eastern Cooperative Oncology Group))Timepoint: Before, and After IV Iron Therapy—

Countries

India

Contacts

Public ContactDr Akshay Batra

Homi Bhabha Cancer Hospital Varanasi (Tata Memorial Centre)

akshay@mpmmcc.tmc.gov.in05426917700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026